From Name:
From Email:
To Name:
To Email:

Optional Message:

Reckitt Benckiser faces generic threats after FDA rejection

from Bloomberg

Reckitt Benckiser Group PLC faces competition in pharmaceuticals for the first time after the Food and Drug Administration approved two generic variants of its Suboxone heroin-dependency drug, thwarting the company's attempts to keep rivals away from its most profitable business. The company said that two manufacturers have FDA approval to produce generic Suboxone tablets in the U.S. Competition could arrive within a month, according to Alex Howson, an analyst at Jefferies International in London. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063